Skip to main content
Top
Published in: CNS Drugs 2/2013

01-02-2013 | Original Research Article

Newly Initiated Opioid Treatment and the Risk of Fall-Related Injuries

A Nationwide, Register-Based, Case-Crossover Study in Sweden

Authors: Karin C. Söderberg, Lucie Laflamme, Jette Möller

Published in: CNS Drugs | Issue 2/2013

Login to get access

Abstract

Background

There is growing epidemiological evidence that opioids may increase the risk of unintentional injuries and it is plausible that the time of initiation is most critical in that respect. Studies on fall-related injuries remain few, limited and mostly focused on specific groups of elderly patients.

Objective

The objective of this study was to assess the short-term effects of newly prescribed opioids on the risk of fall-related injuries in the general adult population.

Methods

A case-crossover design was applied on national register data linking, at the individual level, fall-injury information involving adults aged 18 years and above identified in the Swedish National Inpatient Register (during the period 1 May 2006 to 31 December 2009) and dispensed drugs from the Swedish Prescribed Drug Register (n = 167,257 cases with a first fall-related injury). All types of opioid substances were considered, classified according to the Anatomical Therapeutic Chemical (ATC) classification system. We investigated newly dispensed opioids 28 days preceding the injury, compared with an earlier, and equally long, control period following a 3-month washout period. Conditional logistic regression was used to estimate odds ratio (OR) and 95 % confidence interval (CI). The analyses were also conducted stratified by age group, by type of fall and for each period of 1 week during the 28-day period.

Results

From among the fall-injured patients, 7,450 patients (4.5 %) had a new opioid dispensation within 28 days prior to the injury, of which the most frequent types were tramadol (2.0 %) and codeine (1.1 %). Consistently increased risks of fall-related injuries associated with a new prescription of any opioid were found and they were most pronounced among young adults, 18–29 years of age (OR, 7.17; 95 % CI 5.04–10.2). The closer the dispensation date to the injury, the higher the odds: an OR of 5.14 (95 % CI 4.76–5.55) during the first week of opioid treatment and 1.23 (95 % CI 1.10–1.38) for the fourth week. Of the documented falls, the risk was most pronounced for falls from ‘another, high level’ (OR, 5.33; 95 % CI 3.99–7.10).

Conclusions

Newly prescribed opioids may trigger injurious falls. The effect lowers over time and is less pronounced with increasing age. The risk is also higher for fall from height.
Literature
1.
go back to reference The National Board of Health and Welfare. Systematiskt arbete för äldres säkerhet, om fall, trafikolyckor och bränder. The National Board of Health and Welfare: Stockholm; 2007. The National Board of Health and Welfare. Systematiskt arbete för äldres säkerhet, om fall, trafikolyckor och bränder. The National Board of Health and Welfare: Stockholm; 2007.
2.
go back to reference The National Board of Health and Welfare. Indikatorer för god läkemedelsterapi hos äldre. The National Board of Health and Welfare: Stockholm; 2010. The National Board of Health and Welfare. Indikatorer för god läkemedelsterapi hos äldre. The National Board of Health and Welfare: Stockholm; 2010.
4.
5.
go back to reference Walwyn WM, Miotto KA, Evans CJ. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend. 2010;108(3):156–65.PubMedCrossRef Walwyn WM, Miotto KA, Evans CJ. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend. 2010;108(3):156–65.PubMedCrossRef
6.
go back to reference Friedrich MJ. Research yields new insights into mechanisms and treatment of pain. JAMA. 2012;307(3):239–41.PubMedCrossRef Friedrich MJ. Research yields new insights into mechanisms and treatment of pain. JAMA. 2012;307(3):239–41.PubMedCrossRef
7.
go back to reference Lovell SJ, Taira T, Rodriguez E, et al. Comparison of valdecoxib and an oxycodone-acetaminophen combination for acute musculoskeletal pain in the emergency department: a randomized controlled trial. Acad Emerg Med. 2004;11(12):1278–82.PubMed Lovell SJ, Taira T, Rodriguez E, et al. Comparison of valdecoxib and an oxycodone-acetaminophen combination for acute musculoskeletal pain in the emergency department: a randomized controlled trial. Acad Emerg Med. 2004;11(12):1278–82.PubMed
8.
go back to reference Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172–81.PubMedCrossRef Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci. 2007;62(10):1172–81.PubMedCrossRef
9.
go back to reference von Meyer L. Opioids and driving ability (in German). MMW Fortschr Med. 2006;148(18):33–4. von Meyer L. Opioids and driving ability (in German). MMW Fortschr Med. 2006;148(18):33–4.
10.
go back to reference Buckeridge D, Huang A, Hanley J, et al. Risk of injury associated with opioid use in older adults. J Am Geriatr Soc. 2010;58(9):1664–70.PubMedCrossRef Buckeridge D, Huang A, Hanley J, et al. Risk of injury associated with opioid use in older adults. J Am Geriatr Soc. 2010;58(9):1664–70.PubMedCrossRef
11.
go back to reference Coben JH, Davis SM, Furbee PM, et al. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010;38(5):517–24.PubMedCrossRef Coben JH, Davis SM, Furbee PM, et al. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010;38(5):517–24.PubMedCrossRef
12.
go back to reference Green TC, Grau LE, Carver HW, et al. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997–2007. Drug Alcohol Depend. 2011;115(3):221–8.PubMedCrossRef Green TC, Grau LE, Carver HW, et al. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997–2007. Drug Alcohol Depend. 2011;115(3):221–8.PubMedCrossRef
13.
go back to reference Reith D, Fountain J, Tilyard M. Opioid poisoning deaths in New Zealand (2001–2002). N Z Med J. 2005;118(1209):U1293.PubMed Reith D, Fountain J, Tilyard M. Opioid poisoning deaths in New Zealand (2001–2002). N Z Med J. 2005;118(1209):U1293.PubMed
14.
go back to reference Leung SY. Benzodiazepines, opioids and driving: an overview of the experimental research. Drug Alcohol Rev. 2011;30(3):281–6.PubMedCrossRef Leung SY. Benzodiazepines, opioids and driving: an overview of the experimental research. Drug Alcohol Rev. 2011;30(3):281–6.PubMedCrossRef
15.
go back to reference Kelly KD, Pickett W, Yiannakoulias N, et al. Medication use and falls in community-dwelling older persons. Age Ageing. 2003;32(5):503–9.PubMedCrossRef Kelly KD, Pickett W, Yiannakoulias N, et al. Medication use and falls in community-dwelling older persons. Age Ageing. 2003;32(5):503–9.PubMedCrossRef
16.
go back to reference Baranzini F, Diurni M, Ceccon F, et al. Fall-related injuries in a nursing home setting: is polypharmacy a risk factor? BMC Health Serv Res. 2009;9:228.PubMedCrossRef Baranzini F, Diurni M, Ceccon F, et al. Fall-related injuries in a nursing home setting: is polypharmacy a risk factor? BMC Health Serv Res. 2009;9:228.PubMedCrossRef
17.
go back to reference Kallin K, Gustafson Y, Sandman PO, et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res. 2004;16(4):270–6.PubMed Kallin K, Gustafson Y, Sandman PO, et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res. 2004;16(4):270–6.PubMed
18.
go back to reference Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163(8):949–57.PubMedCrossRef Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003;163(8):949–57.PubMedCrossRef
19.
go back to reference Ebly EM, Hogan DB, Fung TS. Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. J Clin Epidemiol. 1997;50(7):857–63.PubMedCrossRef Ebly EM, Hogan DB, Fung TS. Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. J Clin Epidemiol. 1997;50(7):857–63.PubMedCrossRef
20.
go back to reference Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol. 1998;148(9):887–92.PubMedCrossRef Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol. 1998;148(9):887–92.PubMedCrossRef
21.
go back to reference Walker PC, Alrawi A, Mitchell JF, et al. Medication use as a risk factor for falls among hospitalized elderly patients. AJHP. 2005;62(23):2495–9.PubMed Walker PC, Alrawi A, Mitchell JF, et al. Medication use as a risk factor for falls among hospitalized elderly patients. AJHP. 2005;62(23):2495–9.PubMed
22.
go back to reference Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology. 1998;44(4):217–21.PubMedCrossRef Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology. 1998;44(4):217–21.PubMedCrossRef
23.
go back to reference Moden B, Merlo J, Ohlsson H, et al. Psychotropic drugs and falling accidents among the elderly: a nested case control study in the whole population of Scania, Sweden. J Epidemiol Comm Health. 2010;64(5):440–6.CrossRef Moden B, Merlo J, Ohlsson H, et al. Psychotropic drugs and falling accidents among the elderly: a nested case control study in the whole population of Scania, Sweden. J Epidemiol Comm Health. 2010;64(5):440–6.CrossRef
24.
go back to reference Moden B, Ohlsson H, Merlo J, et al. Psychotropic drugs and accidents in Scania, Sweden. Eur J Public Health. 2012;22(5):726–32.PubMedCrossRef Moden B, Ohlsson H, Merlo J, et al. Psychotropic drugs and accidents in Scania, Sweden. Eur J Public Health. 2012;22(5):726–32.PubMedCrossRef
25.
go back to reference Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260(1):76–87.PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260(1):76–87.PubMedCrossRef
26.
go back to reference Shorr RI, Griffin MR, Daugherty JR, et al. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol. 1992;47(4):M111–5.PubMedCrossRef Shorr RI, Griffin MR, Daugherty JR, et al. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol. 1992;47(4):M111–5.PubMedCrossRef
27.
go back to reference Neutel CI, Hirdes JP, Maxwell CJ, et al. New evidence on benzodiazepine use and falls: the time factor. Age Ageing. 1996;25(4):273–8.PubMedCrossRef Neutel CI, Hirdes JP, Maxwell CJ, et al. New evidence on benzodiazepine use and falls: the time factor. Age Ageing. 1996;25(4):273–8.PubMedCrossRef
29.
go back to reference Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144–53.PubMed Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144–53.PubMed
30.
go back to reference Maclure M, Mittleman MA. Should we use a case-crossover design? Ann Rev Public Health. 2000;21:193–221.CrossRef Maclure M, Mittleman MA. Should we use a case-crossover design? Ann Rev Public Health. 2000;21:193–221.CrossRef
31.
go back to reference Walker AM. Confounding by indication. Epidemiology. 1996;7(4):335–6.PubMed Walker AM. Confounding by indication. Epidemiology. 1996;7(4):335–6.PubMed
32.
go back to reference Schneeweiss S, Sturmer T, Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 1997;6(Suppl. 3):S51–9.PubMedCrossRef Schneeweiss S, Sturmer T, Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 1997;6(Suppl. 3):S51–9.PubMedCrossRef
33.
go back to reference Delaney JA, Suissa S. The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res. 2009;18(1):53–65.PubMedCrossRef Delaney JA, Suissa S. The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res. 2009;18(1):53–65.PubMedCrossRef
35.
go back to reference Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register: opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–35.PubMedCrossRef Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register: opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–35.PubMedCrossRef
37.
go back to reference Handoko KB, Zwart-van Rijkom JE, Hermens WA, et al. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study. Pharmacoepidemiol Drug Saf. 2007;16(2):189–96.PubMedCrossRef Handoko KB, Zwart-van Rijkom JE, Hermens WA, et al. Changes in medication associated with epilepsy-related hospitalisation: a case-crossover study. Pharmacoepidemiol Drug Saf. 2007;16(2):189–96.PubMedCrossRef
38.
go back to reference Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21(2):101–22.PubMedCrossRef Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf. 1999;21(2):101–22.PubMedCrossRef
39.
go back to reference Loeber S, Nakovics H, Kniest A, et al. Factors affecting cognitive function of opiate-dependent patients. Drug Alcohol Depend. 2012;120(1–3):81–7.PubMedCrossRef Loeber S, Nakovics H, Kniest A, et al. Factors affecting cognitive function of opiate-dependent patients. Drug Alcohol Depend. 2012;120(1–3):81–7.PubMedCrossRef
40.
go back to reference Zacny JP, Gutierrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology (Berl). 2003;170(3):242–54.CrossRef Zacny JP, Gutierrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology (Berl). 2003;170(3):242–54.CrossRef
41.
go back to reference Bergstrom MF, Byberg L, Melhus H, et al. Extent and consequences of misclassified injury diagnoses in a national hospital discharge registry. Inj Prev. 2011;17(2):108–13.PubMedCrossRef Bergstrom MF, Byberg L, Melhus H, et al. Extent and consequences of misclassified injury diagnoses in a national hospital discharge registry. Inj Prev. 2011;17(2):108–13.PubMedCrossRef
42.
go back to reference Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.PubMedCrossRef Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.PubMedCrossRef
43.
go back to reference Shah ND, Dunlay SM, Ting HH, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med. 2009;122(10):961 e7–13. Shah ND, Dunlay SM, Ting HH, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med. 2009;122(10):961 e7–13.
44.
Metadata
Title
Newly Initiated Opioid Treatment and the Risk of Fall-Related Injuries
A Nationwide, Register-Based, Case-Crossover Study in Sweden
Authors
Karin C. Söderberg
Lucie Laflamme
Jette Möller
Publication date
01-02-2013
Publisher
Springer International Publishing AG
Published in
CNS Drugs / Issue 2/2013
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.1007/s40263-013-0038-1

Other articles of this Issue 2/2013

CNS Drugs 2/2013 Go to the issue